Fundamental Analysis of Biocardia Inc - Growth / Value Index


BCDA - Valuation Highlights

Valuation Analysis

   Tsr Value Index - Very Poor Score of 5.00
   Price to Book Ratio of 3375.49 suggesting that it is very expensive
   Book Value in last 3 years is trending down
   Book value is negative
Valuation Key Ratios
Ratio TTM Latest FY Yoy Change MRQ
Price to Earning -359.72 -724.85 -122889.87 %
Price to Book 3376.35 -5232.23 -364846.23 % -5.85
Price to Sales 8726.12 17583.37 338663 %
Enterprise Value to EBITDA Multiple -0.860 -724.79 -28104938.94 %


BCDA - Profitability Highlights

Profitability Analysis

   Strong Return On Capital Employed of 721.83
   Company Earning excess return
   Annual Net Profit in last 3 years is trending up
   Company's Net Profit is increasing for last 5 Quarters
   Company's Profit Before Tax is increasing for last 5 Quarters
   EBITDA is continuously increasing for last 3 Years
   Tsr Profitability Index - Very Poor Score of 5.00
   Piotroski F Score - Very Poor Value of 2.0
   Negative Net profit for last two years
   Company Net profit is Negative for last 5 Quarters
   In the last three years, the company has given poor Returns on Equity
   In the last three years, the company has given poor Returns on Assets
   Negative Net Margin MRQ
Profitability Key Ratios
Ratio TTM Latest FY Yoy Change MRQ
Return On Equity -938.60 0 0 % 0
Return On Asset -192.57 -387.38 -218.60 % -69.37
Net Profit Margin -2425.79 -2425.79 -175.44 % -15938.46
Operating Profit Margin -2430.19 -2425.79 -175.58 % -16030.77
EBITDA Margin -2406.29 -2425.79 -177.35 % -15223.08


Highlights
Market Cap10639.53 K
Enterprise Value9869.53 K
Price/Book TTM3376.35
Outstanding Share26867.50 K
Float/ Outstanding Share65.51%
Dividend Yield1.93 %
Share Holding
Guru Numbers
Price/Graham No0
Peter Lynch Ratio0
Piotroski F Score2.00
Altman Z Score-83.87
Sloan Ratio-0.535
Peter Lynch Fair Value0


BCDA - Growth Highlights

Growth Analysis

   YoY Net Margin Jump by 175.44%
   Tsr Growth Index - Very Poor Score of 6.31
   Quarterly sales in last 5 Quarter is trending down
   Companies' sales dropped by 64.72 % from last year
   Company's Total Assets is Decreasing for last 3 years
Growth Key Fields
Field TTM YoY Growth QoQ Growth
Revenue 477000 64.72 % 96.36 %
Gross Profit 372000 64.72 % 125.77 %
EBITDA -11478.00 K 2.15 % 23.12 %
Net Profit -11571.00 K 2.82 % 19.50 %
EPS -0.0011 99.92 % NA


BCDA - Stability Highlights

Stability Analysis

   Debt to equity ratio has decreased and is lowest in last five years
   Tsr Stability Index - Very Poor Score of 5.00
   Altman Z Score of -83.87 suggest high risk
   Company is unable to generate enough free cash to support the business.
   Interest Coverage of 0
Stability Key Ratios
Ratio Latest FY Yoy Change MRQ
Debt to Equity Ratio -0.208 -422.62 % -0.208
Cash Ratio 0.306 -85.12 %
Quick Ratio 0 0 % 0.405
Shareholders Equity -53.67 -207.43 %
Debt to EBITDA -0.0288 -8.03 %


Historical Valuation Ratios of Biocardia Inc

Historical Valuation Ratios
Loading ...

Historical Profitability Ratios of Biocardia Inc

Historical Profitability Ratios
Loading ...

Historical Efficiency Ratios of Biocardia Inc

Historical Efficiency Ratios
Loading ...

Historical Solvency Ratios of Biocardia Inc

Historical Solvency Ratios
Loading ...


Note : All Data Generated at the End of Trading Hours (EOD Data)